Egg Donation in Turkey: How It Works and What to Expect

Egg donation IVF is used by patients who cannot achieve successful pregnancy using their own eggs due to diminished ovarian reserve, premature ovarian insufficiency, genetic conditions, advanced reproductive age or repeated failed IVF cycles with poor egg quality.

It is one of the most effective assisted reproduction options available, with live birth rates per transfer that consistently exceed those of own-egg IVF across most age groups.

Turkey has become a widely used destination for egg donation because the procedure is legally permitted for international patients, clinics have established donor databases, waiting times are shorter than in many regulated European markets and the cost is substantially lower than equivalent treatment in Spain, the Czech Republic or the UK.

Most Turkish fertility clinics with active egg donation programmes treat a high proportion of international patients and have the coordination infrastructure to manage remote communication and cycle logistics.

For patients in countries where egg donation is legally prohibited or severely restricted, Turkey often represents the closest accessible destination combining legal availability, clinical standards and cost efficiency.

Responsible egg donation programmes in Turkey screen donors comprehensively before accepting them into the programme.

Typical screening includes a full hormonal profile to confirm good ovarian reserve, a uterine and pelvic ultrasound, a complete blood count, infectious disease panel including HIV, hepatitis B and C, syphilis and rubella, genetic screening for common carrier conditions including cystic fibrosis and thalassaemia, and a psychological assessment.

Donors are typically recruited between the ages of 20 and 30 to maximise egg quality outcomes. Body mass index, smoking status and absence of significant chronic conditions are also evaluated during the initial assessment. Many programmes also provide recipients with a donor profile including physical characteristics, educational background and health history, while maintaining the donor's anonymity.

Patients should ask clinics specifically which tests form part of their donor screening protocol. Differences in donor health screening depth between clinics can have meaningful implications for outcomes, particularly where infectious disease or genetic carrier status is concerned.

Turkish clinics typically offer egg donation through either a fresh cycle programme or a vitrified egg bank programme. In a fresh cycle, the donor undergoes synchronised stimulation with the recipient's endometrium preparation, and freshly retrieved eggs are fertilised for the specific recipient.

This approach requires donor and recipient cycle coordination, which can introduce scheduling complexity for international patients.

Vitrified egg bank programmes use previously frozen donor eggs that have been cryopreserved after collection. The recipient can schedule their endometrium preparation at a time that works operationally, reducing coordination complexity and travel uncertainty.

Modern vitrification techniques have achieved very high egg survival rates post-thaw, making frozen donor egg outcomes highly competitive with fresh cycle results.

For international patients, the frozen donor egg pathway is often operationally preferable because it allows the recipient's visit to be planned without dependence on donor stimulation timing. Most established Turkish fertility clinics with international patient volumes use vitrified donor egg banks as their primary programme for non-resident recipients.

For a frozen donor egg cycle, the recipient's preparation phase begins several weeks before travel. Endometrium development is supported with oral oestrogen, typically started on day one to three of the cycle. Monitoring via ultrasound is conducted locally during this phase, with scan images and blood results sent to the Turkish clinic.

Once endometrial thickness reaches the required level, the recipient travels to Turkey. The transfer procedure is typically scheduled within one to three days of arrival and is a brief, non-invasive procedure requiring no anaesthesia. Patients usually remain in Turkey for three to four days post-transfer before returning home.

A serum beta-hCG pregnancy test is conducted approximately twelve to fourteen days after transfer, either locally or at the clinic. If pregnancy is confirmed, the clinic will provide a medication tapering plan and advise on the timing of the first obstetric scan.

Egg donation IVF is legal in Turkey and available to international patients. However, patients should be aware of how their home country treats children born from egg donation IVF conducted abroad. In many countries, the birth mother is legally recognised as the mother irrespective of genetic origin, which means there is no practical legal barrier to treatment abroad.

Some countries require donor anonymity while others permit or require donor identity disclosure to children upon request at adult age. The legal framework governing anonymous versus identity-release donation varies significantly across Europe and other regions. Patients should verify whether the donation arrangement at the Turkish clinic aligns with their preferences and with any relevant domestic legal context.

NexWell recommends that patients with specific legal questions about cross-border egg donation consult a specialist solicitor or family law practitioner in their home country before treatment, as the legal landscape continues to evolve across jurisdictions.

NexWell assists patients evaluating egg donation programmes in Turkey by reviewing the clinic's donor screening protocol, success rate data and coordination model for international recipients. We evaluate whether the published outcome data is transparent, whether the donor database is active enough to provide reasonable matching options and whether the cost structure is complete and clear.

For patients with specific medical histories including recurrent implantation failure, autoimmune conditions or prior cycles at other clinics, we check whether the Turkish clinic's evaluation approach is appropriately thorough rather than proceeding directly to donation without investigating potential receptivity factors.

We also help patients understand the timing implications of fresh versus frozen donor programmes and assist with pre-cycle coordination logistics including remote monitoring, medication procurement and travel planning.